Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique [SFPO]) Guidelines.
Identifieur interne : 000846 ( Main/Exploration ); précédent : 000845; suivant : 000847Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique [SFPO]) Guidelines.
Auteurs : Bertrand Pourroy [France] ; Jean Francois Tournamille [France] ; Christophe Bardin [France] ; Florian Slimano [France] ; Régine Chevrier [France] ; Catherine Rioufol [France] ; Isabelle Madelaine [France]Source :
- JCO oncology practice [ 2688-1535 ] ; 2020.
Abstract
PURPOSE
Patients with cancer are at higher risk for contracting the COVID-19 infection and are more likely to have higher morbidity and mortality. This is a big challenge for oncology teams that have to treat patients to avoid contamination by SARS-CoV-2. The aim of the current work is to present oncology pharmacy practice guidelines during the COVID-19 pandemic to secure the pharmaceutical care of patients with cancer.
METHODS
The bureau of the French Society for Oncology Pharmacy proposed these recommendations according to the French High Authority of Health following the Guidelines of Good Practice, slightly modified according to the pandemic crisis situation. These guidelines were developed by a working group of 7 experts in oncology pharmacy practice. Furthermore, the guidelines were assessed by 31 independent reviewers.
RESULTS
One hundred percent of reviewers approved the guidelines and 90% of them suggested some improvements. The final version incorporates the best comments and consists of 26 recommendations organized in 8 different sections.
CONCLUSION
These guidelines allow secure pharmaceutical management of patients with cancer during the COVID-19 pandemic.
DOI: 10.1200/OP.20.00295
PubMed: 32539650
Affiliations:
- France
- Auvergne (région administrative), Auvergne-Rhône-Alpes, Champagne-Ardenne, Grand Est, Provence-Alpes-Côte d'Azur, Rhône-Alpes, Île-de-France
- Clermont-Ferrand, Lyon, Marseille, Paris, Reims
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique [SFPO]) Guidelines.</title><author><name sortKey="Pourroy, Bertrand" sort="Pourroy, Bertrand" uniqKey="Pourroy B" first="Bertrand" last="Pourroy">Bertrand Pourroy</name><affiliation wicri:level="3"><nlm:affiliation>Oncopharma Unit, La Timone University Teaching Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Oncopharma Unit, La Timone University Teaching Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>French Society for Oncology Pharmacy, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Oncology Pharmacy, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Tournamille, Jean Francois" sort="Tournamille, Jean Francois" uniqKey="Tournamille J" first="Jean Francois" last="Tournamille">Jean Francois Tournamille</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Oncology Pharmacy, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Oncology Pharmacy, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Bardin, Christophe" sort="Bardin, Christophe" uniqKey="Bardin C" first="Christophe" last="Bardin">Christophe Bardin</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Oncology Pharmacy, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Oncology Pharmacy, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Pharmacy Department, Cochin University Teaching Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pharmacy Department, Cochin University Teaching Hospital, Assistance Publique-Hôpitaux de Paris, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Slimano, Florian" sort="Slimano, Florian" uniqKey="Slimano F" first="Florian" last="Slimano">Florian Slimano</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Oncology Pharmacy, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Oncology Pharmacy, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Pharmacy, Centre Hospitalier Universitaire Reims; and Faculty of Pharmacy, EA7506, Université de Reims Champagne-Ardenne, Reims, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pharmacy, Centre Hospitalier Universitaire Reims; and Faculty of Pharmacy, EA7506, Université de Reims Champagne-Ardenne, Reims</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Champagne-Ardenne</region><settlement type="city">Reims</settlement></placeName></affiliation></author><author><name sortKey="Chevrier, Regine" sort="Chevrier, Regine" uniqKey="Chevrier R" first="Régine" last="Chevrier">Régine Chevrier</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Oncology Pharmacy, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Oncology Pharmacy, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Pharmacy Department, Jean Perrin Cancer Center, Clermont Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pharmacy Department, Jean Perrin Cancer Center, Clermont Ferrand</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Auvergne (région administrative)</region><settlement type="city">Clermont-Ferrand</settlement></placeName></affiliation></author><author><name sortKey="Rioufol, Catherine" sort="Rioufol, Catherine" uniqKey="Rioufol C" first="Catherine" last="Rioufol">Catherine Rioufol</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Oncology Pharmacy, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Oncology Pharmacy, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Oncology Clinical Pharmacy Unit, Lyon Sud University Teaching Hospital. Hospices Civils de Lyon, Pierre-Bénite; and EMR3738, Lyon University, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Oncology Clinical Pharmacy Unit, Lyon Sud University Teaching Hospital. Hospices Civils de Lyon, Pierre-Bénite; and EMR3738, Lyon University, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Madelaine, Isabelle" sort="Madelaine, Isabelle" uniqKey="Madelaine I" first="Isabelle" last="Madelaine">Isabelle Madelaine</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Oncology Pharmacy, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Oncology Pharmacy, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Pharmacy Department, Saint Louis University Teaching Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pharmacy Department, Saint Louis University Teaching Hospital, Assistance Publique-Hôpitaux de Paris, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32539650</idno><idno type="pmid">32539650</idno><idno type="doi">10.1200/OP.20.00295</idno><idno type="wicri:Area/Main/Corpus">000D91</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000D91</idno><idno type="wicri:Area/Main/Curation">000D91</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000D91</idno><idno type="wicri:Area/Main/Exploration">000D91</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique [SFPO]) Guidelines.</title><author><name sortKey="Pourroy, Bertrand" sort="Pourroy, Bertrand" uniqKey="Pourroy B" first="Bertrand" last="Pourroy">Bertrand Pourroy</name><affiliation wicri:level="3"><nlm:affiliation>Oncopharma Unit, La Timone University Teaching Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Oncopharma Unit, La Timone University Teaching Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille</wicri:regionArea><placeName><region type="region">Provence-Alpes-Côte d'Azur</region><region type="old region">Provence-Alpes-Côte d'Azur</region><settlement type="city">Marseille</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>French Society for Oncology Pharmacy, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Oncology Pharmacy, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Tournamille, Jean Francois" sort="Tournamille, Jean Francois" uniqKey="Tournamille J" first="Jean Francois" last="Tournamille">Jean Francois Tournamille</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Oncology Pharmacy, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Oncology Pharmacy, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Bardin, Christophe" sort="Bardin, Christophe" uniqKey="Bardin C" first="Christophe" last="Bardin">Christophe Bardin</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Oncology Pharmacy, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Oncology Pharmacy, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Pharmacy Department, Cochin University Teaching Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pharmacy Department, Cochin University Teaching Hospital, Assistance Publique-Hôpitaux de Paris, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Slimano, Florian" sort="Slimano, Florian" uniqKey="Slimano F" first="Florian" last="Slimano">Florian Slimano</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Oncology Pharmacy, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Oncology Pharmacy, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Pharmacy, Centre Hospitalier Universitaire Reims; and Faculty of Pharmacy, EA7506, Université de Reims Champagne-Ardenne, Reims, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pharmacy, Centre Hospitalier Universitaire Reims; and Faculty of Pharmacy, EA7506, Université de Reims Champagne-Ardenne, Reims</wicri:regionArea><placeName><region type="region">Grand Est</region><region type="old region">Champagne-Ardenne</region><settlement type="city">Reims</settlement></placeName></affiliation></author><author><name sortKey="Chevrier, Regine" sort="Chevrier, Regine" uniqKey="Chevrier R" first="Régine" last="Chevrier">Régine Chevrier</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Oncology Pharmacy, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Oncology Pharmacy, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Pharmacy Department, Jean Perrin Cancer Center, Clermont Ferrand, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pharmacy Department, Jean Perrin Cancer Center, Clermont Ferrand</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Auvergne (région administrative)</region><settlement type="city">Clermont-Ferrand</settlement></placeName></affiliation></author><author><name sortKey="Rioufol, Catherine" sort="Rioufol, Catherine" uniqKey="Rioufol C" first="Catherine" last="Rioufol">Catherine Rioufol</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Oncology Pharmacy, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Oncology Pharmacy, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Oncology Clinical Pharmacy Unit, Lyon Sud University Teaching Hospital. Hospices Civils de Lyon, Pierre-Bénite; and EMR3738, Lyon University, Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Oncology Clinical Pharmacy Unit, Lyon Sud University Teaching Hospital. Hospices Civils de Lyon, Pierre-Bénite; and EMR3738, Lyon University, Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Madelaine, Isabelle" sort="Madelaine, Isabelle" uniqKey="Madelaine I" first="Isabelle" last="Madelaine">Isabelle Madelaine</name><affiliation wicri:level="3"><nlm:affiliation>French Society for Oncology Pharmacy, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>French Society for Oncology Pharmacy, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="3"><nlm:affiliation>Pharmacy Department, Saint Louis University Teaching Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Pharmacy Department, Saint Louis University Teaching Hospital, Assistance Publique-Hôpitaux de Paris, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></analytic><series><title level="j">JCO oncology practice</title><idno type="eISSN">2688-1535</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>PURPOSE</b></p><p>Patients with cancer are at higher risk for contracting the COVID-19 infection and are more likely to have higher morbidity and mortality. This is a big challenge for oncology teams that have to treat patients to avoid contamination by SARS-CoV-2. The aim of the current work is to present oncology pharmacy practice guidelines during the COVID-19 pandemic to secure the pharmaceutical care of patients with cancer.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>The bureau of the French Society for Oncology Pharmacy proposed these recommendations according to the French High Authority of Health following the Guidelines of Good Practice, slightly modified according to the pandemic crisis situation. These guidelines were developed by a working group of 7 experts in oncology pharmacy practice. Furthermore, the guidelines were assessed by 31 independent reviewers.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>One hundred percent of reviewers approved the guidelines and 90% of them suggested some improvements. The final version incorporates the best comments and consists of 26 recommendations organized in 8 different sections.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>These guidelines allow secure pharmaceutical management of patients with cancer during the COVID-19 pandemic.</p></div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32539650</PMID><DateRevised><Year>2020</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2688-1535</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Jun</Month><Day>15</Day></PubDate></JournalIssue><Title>JCO oncology practice</Title><ISOAbbreviation>JCO Oncol Pract</ISOAbbreviation></Journal><ArticleTitle>Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique [SFPO]) Guidelines.</ArticleTitle><Pagination><MedlinePgn>OP2000295</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1200/OP.20.00295</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Patients with cancer are at higher risk for contracting the COVID-19 infection and are more likely to have higher morbidity and mortality. This is a big challenge for oncology teams that have to treat patients to avoid contamination by SARS-CoV-2. The aim of the current work is to present oncology pharmacy practice guidelines during the COVID-19 pandemic to secure the pharmaceutical care of patients with cancer.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The bureau of the French Society for Oncology Pharmacy proposed these recommendations according to the French High Authority of Health following the Guidelines of Good Practice, slightly modified according to the pandemic crisis situation. These guidelines were developed by a working group of 7 experts in oncology pharmacy practice. Furthermore, the guidelines were assessed by 31 independent reviewers.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">One hundred percent of reviewers approved the guidelines and 90% of them suggested some improvements. The final version incorporates the best comments and consists of 26 recommendations organized in 8 different sections.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">These guidelines allow secure pharmaceutical management of patients with cancer during the COVID-19 pandemic.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pourroy</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Oncopharma Unit, La Timone University Teaching Hospital, Assistance Publique-Hôpitaux de Marseille, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>French Society for Oncology Pharmacy, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tournamille</LastName><ForeName>Jean Francois</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>French Society for Oncology Pharmacy, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bardin</LastName><ForeName>Christophe</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>French Society for Oncology Pharmacy, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pharmacy Department, Cochin University Teaching Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slimano</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>French Society for Oncology Pharmacy, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pharmacy, Centre Hospitalier Universitaire Reims; and Faculty of Pharmacy, EA7506, Université de Reims Champagne-Ardenne, Reims, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chevrier</LastName><ForeName>Régine</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>French Society for Oncology Pharmacy, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pharmacy Department, Jean Perrin Cancer Center, Clermont Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rioufol</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>French Society for Oncology Pharmacy, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oncology Clinical Pharmacy Unit, Lyon Sud University Teaching Hospital. Hospices Civils de Lyon, Pierre-Bénite; and EMR3738, Lyon University, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madelaine</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>French Society for Oncology Pharmacy, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pharmacy Department, Saint Louis University Teaching Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JCO Oncol Pract</MedlineTA><NlmUniqueID>101758685</NlmUniqueID><ISSNLinking>2688-1527</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32539650</ArticleId><ArticleId IdType="doi">10.1200/OP.20.00295</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Auvergne (région administrative)</li><li>Auvergne-Rhône-Alpes</li><li>Champagne-Ardenne</li><li>Grand Est</li><li>Provence-Alpes-Côte d'Azur</li><li>Rhône-Alpes</li><li>Île-de-France</li></region><settlement><li>Clermont-Ferrand</li><li>Lyon</li><li>Marseille</li><li>Paris</li><li>Reims</li></settlement></list><tree><country name="France"><region name="Provence-Alpes-Côte d'Azur"><name sortKey="Pourroy, Bertrand" sort="Pourroy, Bertrand" uniqKey="Pourroy B" first="Bertrand" last="Pourroy">Bertrand Pourroy</name></region><name sortKey="Bardin, Christophe" sort="Bardin, Christophe" uniqKey="Bardin C" first="Christophe" last="Bardin">Christophe Bardin</name><name sortKey="Bardin, Christophe" sort="Bardin, Christophe" uniqKey="Bardin C" first="Christophe" last="Bardin">Christophe Bardin</name><name sortKey="Chevrier, Regine" sort="Chevrier, Regine" uniqKey="Chevrier R" first="Régine" last="Chevrier">Régine Chevrier</name><name sortKey="Chevrier, Regine" sort="Chevrier, Regine" uniqKey="Chevrier R" first="Régine" last="Chevrier">Régine Chevrier</name><name sortKey="Madelaine, Isabelle" sort="Madelaine, Isabelle" uniqKey="Madelaine I" first="Isabelle" last="Madelaine">Isabelle Madelaine</name><name sortKey="Madelaine, Isabelle" sort="Madelaine, Isabelle" uniqKey="Madelaine I" first="Isabelle" last="Madelaine">Isabelle Madelaine</name><name sortKey="Pourroy, Bertrand" sort="Pourroy, Bertrand" uniqKey="Pourroy B" first="Bertrand" last="Pourroy">Bertrand Pourroy</name><name sortKey="Rioufol, Catherine" sort="Rioufol, Catherine" uniqKey="Rioufol C" first="Catherine" last="Rioufol">Catherine Rioufol</name><name sortKey="Rioufol, Catherine" sort="Rioufol, Catherine" uniqKey="Rioufol C" first="Catherine" last="Rioufol">Catherine Rioufol</name><name sortKey="Slimano, Florian" sort="Slimano, Florian" uniqKey="Slimano F" first="Florian" last="Slimano">Florian Slimano</name><name sortKey="Slimano, Florian" sort="Slimano, Florian" uniqKey="Slimano F" first="Florian" last="Slimano">Florian Slimano</name><name sortKey="Tournamille, Jean Francois" sort="Tournamille, Jean Francois" uniqKey="Tournamille J" first="Jean Francois" last="Tournamille">Jean Francois Tournamille</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000846 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000846 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32539650
|texte= Providing Oncology Pharmacy Services During the Coronavirus Pandemic: French Society for Oncology Pharmacy (Société Francaise de Pharmacie Oncologique [SFPO]) Guidelines.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32539650" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |